Advertisement: TTP Killer 50

The Killer 50 Profiles

  • Abcam

    Abcam cgi Cambridge

    A global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research,... Read More

  • Arecor

    Sarah Howell of Arecor

    Arecor’s next-generation diabetes product pipeline represents exciting technology progress in the field of diabetes that will enable important new... Read More

  • ARM Holdings

    ARM Cambridge

    Superchip architect and Internet of Things pioneer ARM Holdings had a market cap of around $21bn when it was acquired by Japanese group SoftBank for... Read More

  • Artios Pharma

    Niall Martin of Artios Pharma

    Artios Pharma, a leading DNA Damage Response company developing innovative treatments for cancer, completed an $84 million Series B financing in... Read More

  • AstraZeneca

    AstraZeneca Cambridge

    The global science-led biopharma business whose medicines are used by millions of patients worldwide is creating an estimated 2,500 jobs at a new... Read More

  • AVEVA

    A world-leading engineering software provider to the plant, power and marine industries, AVEVA is 50 years old and has significantly expanded its... Read More

  • Bango

    bango, cambridge, mobile payments

    Founded in 1999 and listed on The London Stock Exchange (AIM: BGO) in 2005, the Bango Platform is deployed with the world's leading app stores.... Read More

  • Bicycle Therapeutics

    Bicycle Greg Winter

    Bicycle Therapeutics was founded in 2009 based on innovative science conducted in the laboratory of the globally respected Professor Sir Greg Winter... Read More

  • Cambridge Cancer Genomics

    John Cassidy Cambridge Cancer Genomics

    The health technology company is building tools to enable oncologists to make the best therapeutic decisions for their patients. Cambridge Cancer... Read More

  • Cambridge Consultants

    Cambridge Consultants x-ray

    Founded in 1960, product design hothouse Cambridge Consultants won a Queen’s Award for International Trade in April 2017.  It is the founding... Read More

  • Cambridge Epigenetix

    Cambridge Epigenetix (CEGX) is a rapidly growing company focused on developing innovative methods and technologies to revolutionise the fields of... Read More

  • CellCentric

    CellCentric is actively pursuing novel drug discovery against a histone demethylase, a ubiquitin modifier and two histone methyltransferase targets.... Read More

  • CMR Surgical

    Cambridge Medical Robotics

    Cambridge Medical Robotics is developing a next-gen universal robotic system for minimal access surgery. The company aims to make minimal access (... Read More

  • Congenica

    bic Congenica

    Congenica is a spin-out from the Wellcome Trust Sanger Institute and a leading developer of clinical genomics software for inherited diseases.... Read More

  • Crescendo Biologics

    Theodora Harold

    Crescendo Biologics is developing innovative new medicines based on its best-in-class antibody fragment technology. Crescendo’s Humabody™ approach... Read More

  • Darktrace

    Darktrace cyber technology

    The cyber defence business’ self-learning technology – the Enterprise Immune System – has been deployed over 4,000 times worldwide and in May 2017... Read More

  • DisplayLink

    Named Business Weekly’s International Trade Champion in March 2017, DisplayLink is a chip and software company whose technology is used in products... Read More

  • Domino Printing Sciences

    i-Tech Domino

    Founded in 1978, Domino is a world leader in inkjet coding and printing technologies that meet the needs of manufacturers. In April 2017, the company... Read More

  • Evonetix

    Evonetix McCook

    Cambridge Consultants spin-out, Evonetix aims to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging... Read More

  • F-star

    F-star, biopharma, antibodies, cambridge

    Antibodies specialist F-star won the Life Science Innovation category, sponsored by AstraZeneca and MedImmune, at the March 2017 Business Weekly... Read More

Pages